Ahmet Dirican, Professor of Medical Oncology at Medicana International İzmir Hospital, shared on X:
“Cancer vaccines: After 100 years of setbacks, are we finally getting closer?
My key takeaways from ESMO 2026:
- Personalized mRNA vaccines may generate durable T-cell immunity, even in low-TMB tumors.
- Promising signals in pancreatic cancer and melanoma.
- Phase III validation and broader access remain critical.
The next frontier in precision oncology?”
You can also read:
Where to Take the Best Breaks at ESMO Congress 2026: Coffee, Sweets, and a Little Fun
